Page last updated: 2024-09-04

sweroside and 1-naphthylisothiocyanate

sweroside has been researched along with 1-naphthylisothiocyanate in 1 studies

Compound Research Comparison

Studies
(sweroside)
Trials
(sweroside)
Recent Studies (post-2010)
(sweroside)
Studies
(1-naphthylisothiocyanate)
Trials
(1-naphthylisothiocyanate)
Recent Studies (post-2010) (1-naphthylisothiocyanate)
780574140142

Protein Interaction Comparison

ProteinTaxonomysweroside (IC50)1-naphthylisothiocyanate (IC50)
Cytochrome P450 1A2Homo sapiens (human)1
Alpha-2A adrenergic receptorHomo sapiens (human)6.272
Adenosine receptor A3Homo sapiens (human)6.1
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)6.1
C-C chemokine receptor type 2Homo sapiens (human)6.699
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)6.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, JT; Tang, XW; Wang, GY; Wang, ZT; Yang, F; Yang, L; Yang, QL1

Other Studies

1 other study(ies) available for sweroside and 1-naphthylisothiocyanate

ArticleYear
Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:9

    Topics: 1-Naphthylisothiocyanate; Animals; Anti-Inflammatory Agents; Bile Acids and Salts; Biomarkers; Cell Survival; Cholestasis; Disease Models, Animal; Gene Expression; Hepatocytes; Immunologic Factors; Iridoid Glucosides; Liver; Male; Mice; Mice, Inbred C57BL; Primary Cell Culture

2016